age at least 18 Years
Item
Alter mindestens 18 Jahre
boolean
C0001779 (UMLS CUI 2011AA)
397669002 (SNOMED CT 2011_0131)
Skin type I, II, or III according to Fitzpatrick
Item
Skin type I, II, or III according to Fitzpatrick
boolean
C2700185 (UMLS CUI 2011AA)
C2700186 (UMLS CUI 2011AA)
C2700187 (UMLS CUI 2011AA)
Subjects of childbearing potential must use an acceptable method of contraception. Hormonal or oral contraceptive drugs, intra-uterine devices (IUD) and abstinence are considered acceptable methods of contraception.
Item
Subjects of childbearing potential must use an acceptable method of contraception. Hormonal or oral contraceptive drugs, intra-uterine devices (IUD) and abstinence are considered acceptable methods of contraception.
boolean
C0681850 (UMLS CUI 2011AA)
C1148523 (UMLS CUI 2011AA)
C0237399 (UMLS CUI 2011AA)
C0700589 (UMLS CUI 2011AA)
146680009 (SNOMED CT 2011_0131)
10010808 (MedDRA 14.1)
CL424941 (UMLS CUI 2011AA)
C0009905 (UMLS CUI 2011AA)
59261009 (SNOMED CT 2011_0131)
C0021900 (UMLS CUI 2011AA)
268460000 (SNOMED CT 2011_0131)
10022745 (MedDRA 14.1)
C0036899 (UMLS CUI 2011AA)
47037006 (SNOMED CT 2011_0131)
10029805 (MedDRA 14.1)
Clinical history suggestive of intolerance, allergies or idiosyncrasies to one of the products or the ingredients of the products including the patch.
Item
Clinical history suggestive of intolerance, allergies or idiosyncrasies to one of the products or the ingredients of the products including the patch.
boolean
C0427350 (UMLS CUI 2011AA)
250171008 (SNOMED CT 2011_0131)
C1744706 (UMLS CUI 2011AA)
C0552536 (UMLS CUI 2011AA)
MTHU002637 (LOINC Version 232)
C0919578 (UMLS CUI 2011AA)
10049998 (MedDRA 14.1)
C0304229 (UMLS CUI 2011AA)
902003 (SNOMED CT 2011_0131)
CL414967 (UMLS CUI 2011AA)
C2242995 (UMLS CUI 2011AA)
Known skin allergies.
Item
Allergie der Haut, kutane Hypersensitivität
boolean
C0585186 (UMLS CUI 2011AA)
21626009 (SNOMED CT 2011_0131)
10011667 (MedDRA 14.1)
Dermatologic diseases that might interfere with the evaluation of test site reaction.
Item
Dermatologic diseases that might interfere with the evaluation of test site reaction.
boolean
C0037274 (UMLS CUI 2011AA)
95320005 (SNOMED CT 2011_0131)
10048768, 10040831 (MedDRA 14.1)
MTHU031899 (LOINC Version 232)
C0521102 (UMLS CUI 2011AA)
78235001 (SNOMED CT 2011_0131)
C0220825 (UMLS CUI 2011AA)
C0392366 (UMLS CUI 2011AA)
272393004 (SNOMED CT 2011_0131)
C0205145 (UMLS CUI 2011AA)
10546003 (SNOMED CT 2011_0131)
MTHU014632 (LOINC Version 232)
C0443286 (UMLS CUI 2011AA)
263851003 (SNOMED CT 2011_0131)
MTHU014636 (LOINC Version 232)
Other(s), considered as important by the investigator (e.g. multiple birth marks in the test area, important hair growth in the test area, pigmented or extremely suntanned skin impairing visual assessment, tattoos in the test area.
Item
Other(s), considered as important by the investigator (e.g. multiple birth marks in the test area, important hair growth in the test area, pigmented or extremely suntanned skin impairing visual assessment, tattoos in the test area.
boolean
C0392366 (UMLS CUI 2011AA)
272393004 (SNOMED CT 2011_0131)
C0205146 (UMLS CUI 2011AA)
42798000 (SNOMED CT 2011_0131)
MTHU009059 (LOINC Version 232)
C0439064 (UMLS CUI 2011AA)
255204007 (SNOMED CT 2011_0131)
C0852910 (UMLS CUI 2011AA)
10004950 (MedDRA 14.1)
C0232407 (UMLS CUI 2011AA)
88911008 (SNOMED CT 2011_0131)
C0262595 (UMLS CUI 2011AA)
201340008 (SNOMED CT 2011_0131)
C0406208 (UMLS CUI 2011AA)
238516007 (SNOMED CT 2011_0131)
C0221258 (UMLS CUI 2011AA)
Topical use of any cosmetic preparation on the test areas within 5 days prior to Day 1 (Start of Treatment) or during the trial
Item
Topical use of any cosmetic preparation on the test areas within 5 days prior to Day 1 (Start of Treatment) or during the trial
boolean
C0010164 (UMLS CUI 2011AA)
81024003 (SNOMED CT 2011_0131)
MTHU035662 (LOINC Version 232)
C0360289 (UMLS CUI 2011AA)
350088003 (SNOMED CT 2011_0131)
C0392366 (UMLS CUI 2011AA)
272393004 (SNOMED CT 2011_0131)
C0205146 (UMLS CUI 2011AA)
42798000 (SNOMED CT 2011_0131)
MTHU009059 (LOINC Version 232)
Within 3 weeks prior to Day 1 and during the entire trial. Any systemic or topical medication likely to interfere with the trial purposes: e.g. immune-modulating therapy (e.g. corticosteroids, cytotoxics or immunosuppressants) and any dermatological medication (drug or medical device.
Item
Within 3 weeks prior to Day 1 and during the entire trial. Any systemic or topical medication likely to interfere with the trial purposes: e.g. immune-modulating therapy (e.g. corticosteroids, cytotoxics or immunosuppressants) and any dermatological medication (drug or medical device.
boolean
C0205373 (UMLS CUI 2011AA)
31099001 (SNOMED CT 2011_0131)
C0013227 (UMLS CUI 2011AA)
C1644713 (UMLS CUI 2011AA)
419487009 (SNOMED CT 2011_0131)
C0521102 (UMLS CUI 2011AA)
78235001 (SNOMED CT 2011_0131)
C0681832 (UMLS CUI 2011AA)
C0678889 (UMLS CUI 2011AA)
C0039798 (UMLS CUI 2011AA)
C0001617 (UMLS CUI 2011AA)
79440004 (SNOMED CT 2011_0131)
C0304497 (UMLS CUI 2011AA)
373526007 (SNOMED CT 2011_0131)
C0021081 (UMLS CUI 2011AA)
372823004, 69431002 (SNOMED CT 2011_0131)
C0011625 (UMLS CUI 2011AA)
65628000 (SNOMED CT 2011_0131)
Within 1 week prior to Day 1 and during the entire trial any medication with common effects on the perfusion of skin vessels (e.g. vasodilators or vasoconstrictors, beta-receptor blocking drugs, antihistamines) should not be used.
Item
Within 1 week prior to Day 1 and during the entire trial any medication with common effects on the perfusion of skin vessels (e.g. vasodilators or vasoconstrictors, beta-receptor blocking drugs, antihistamines) should not be used.
boolean
C0013227 (UMLS CUI 2011AA)
C1280500 (UMLS CUI 2011AA)
253861007 (SNOMED CT 2011_0131)
C0031001 (UMLS CUI 2011AA)
88058003 (SNOMED CT 2011_0131)
C1123023 (UMLS CUI 2011AA)
39937001 (SNOMED CT 2011_0131)
MTHU001414 (LOINC Version 232)
C0042591 (UMLS CUI 2011AA)
272735005 (SNOMED CT 2011_0131)
C0042402 (UMLS CUI 2011AA)
58944007 (SNOMED CT 2011_0131)
C0042397 (UMLS CUI 2011AA)
8571001 (SNOMED CT 2011_0131)
C0001645 (UMLS CUI 2011AA)
33252009 (SNOMED CT 2011_0131)
MTHU003324 (LOINC Version 232)
C0003360 (UMLS CUI 2011AA)
372806008 (SNOMED CT 2011_0131)
MTHU003328 (LOINC Version 232)